medigraphic.com
Órgano oficial de la Sociedad Mexicana de Cirugía Dermatológica y Oncológica, AC

2015, Number 4

<< Back Next >>

Dermatología Cosmética, Médica y Quirúrgica 2015; 13 (4)

Hyperuricemia and psoriasis. An old relationship with new implications

Hernández CAA, Villanueva QG, Alvarado NA, Poletti VED

Language: Spanish
References: 30
Page: 336-339
PDF size: 127.21 Kb.


ABSTRACT

Since 1958, the study of hyperuricemia in patients with psoriasis has been controversial. Currently, this hiperuricemia should be monitored for diminish complications related to the elevation of uric acid such as: further evolution of asymptomatic hyperuricemia to clinical variants of gout (arthritis, tophi, ureteral stones), predisposition to the development of psoriatic arthritis by joint cross reactivity to amorphous urate crystals and increased cardiovascular risk. These findings suggest the need for uric acid measurement in patients with newly diagnosed psoriasis and regular check up to assess the improvement and evolution of the disease. The research of hyperuricemia in psoriasis is promising as prognostic scale and cardiovascular and renal risk prediction can be obtained.


REFERENCES

  1. International Psoriasis Council, “Revisión de la ipc sobre la psoriasis”, diciembre de 2009, en http://www.psoriasiscouncil.org/docs/ ipcpsoriasisreview_dec_2009_spanish.pdf?LanguageID=EN-US. Último acceso: mayo de 2015.

  2. Kim, J. y Krueger, J.G., “The immunopathogenesis of psoriasis”, Dermatol Clin, 2015, 33: 13-23.

  3. Lobitz, W. y Brunsting, L., “Unpublished Studies”, en Ormsby, O.S. y Montgomery, H., Diseases of the Skin, 7a ed., Filadelfia, 1948: 312.

  4. Eisen, A.Z. y Seegmiller, J.E., “Uric acid metabolism in psoriasis”, J Clin Invest, 1961, 40: 1486.

  5. Lea, W. A., Jr., Curtis, A. C. y Bernstein, I. A., “Serum uric acid levels in psoriasis”, J Invest Dermatol, 1958, 31: 269-271.

  6. Gisondi, P., Targher, G., Cagalli, A. y Girolomoni, G., “Hyperuricemia in patients with chronic plaque psoriasis”, J Am Acad Dermatol, 2014, 70: 127-130.

  7. Kwon, H.H., Kwon, I.H., Choi, J.W. y Youn, J.I., “Cross-sectional study on the correlation of serum uric acid with disease severity in Korean patients with psoriasis”, Clin Exp Dermatol, 2011, 36: 473-478.

  8. Bruce, I.N., Schentag, C.T. y Gladman, D.D., “Hyperuricemia in psoriatic arthritis: prevalence and associated features”, J Clin Rheumatol, 2000, 6: 6-9.

  9. Isha, I., Jain, V.K. y Lal, H., “C-reactive protein and uric acid levels in patients with psoriasis”, Indian J Clin Biochem, 2011, 26: 309-311.

  10. Gür, M., Sahin, D.Y., Elbasan, Z., Kalkan, G.Y., Yildiz, A., Kaya, Z., Ozaltun, B. y Caylin, M., “Uric acid and high sensitive c-reactive protein are associated with subclinical thoracic aortic atherosclerosis”, J Cardiol, 2013, 61: 144-148.

  11. Ibrahim, S.E., Helmi, A., Yousef, T.M., Hassan, M.S. y Farouk, N., “Association of asymptomatic hyperuricemia and endothelial dysfunction in psoriatic arthritis”, The Egyptian Rheumatologist, 2012; 34: 83-89.

  12. Merola, J.F., Wu, S., Han, J., Choi, H.K. y Qureshi, A.A., “Psoriasis, psoriatic arthritis and risk of gout in US men and women”, Ann Rheum Dis, 2015, 74 (8): 1495-1500.

  13. Akkineni, R., Tapp, S., Tosteson, A.N., Lee, A., Miller, K.L., Choi, H.K., Zhu, Y. y Albert, D.A., “Treatment of asymptomatic hyperuricemia and prevention of vascular disease: a decision analytic approach”, J Rheumatol, 2014, 41: 739-748.

  14. Wan, J., Wang, S., Haynes, K., Denburg, M.R., Shin, D.B., Gelfand, J.M. et al., “Risk of moderate to advanced kidney disease in patients with psoriasis: population based cohort study”, bmj, 2013, 347: f5961.

  15. Daoussis, D., Panoulas, V., Toms, T., John, H., Antonopoulos, I., Nightingale, P., Douglas, K., Klocke, R. y Kitas, G.D., “Uric acid is a strong independent predictor of renal dysfunctcion in patients with rheumatoid arthritis”, Arthritis Res Ther, 2009, 11: R116.

  16. International Psoriasis Council, “Revisión de la ipc sobre la psoriasis”, diciembre de 2009, en http://www.psoriasiscouncil.org/docs/ ipcpsoriasisreview_dec_2009_spanish.pdf?LanguageID=EN-US. Último acceso: mayo de 2015.

  17. Kim, J. y Krueger, J.G., “The immunopathogenesis of psoriasis”, Dermatol Clin, 2015, 33: 13-23.

  18. Lobitz, W. y Brunsting, L., “Unpublished Studies”, en Ormsby, O.S. y Montgomery, H., Diseases of the Skin, 7a ed., Filadelfia, 1948: 312.

  19. Eisen, A.Z. y Seegmiller, J.E., “Uric acid metabolism in psoriasis”, J Clin Invest, 1961, 40: 1486.

  20. Lea, W. A., Jr., Curtis, A. C. y Bernstein, I. A., “Serum uric acid levels in psoriasis”, J Invest Dermatol, 1958, 31: 269-271.

  21. Gisondi, P., Targher, G., Cagalli, A. y Girolomoni, G., “Hyperuricemia in patients with chronic plaque psoriasis”, J Am Acad Dermatol, 2014, 70: 127-130.

  22. Kwon, H.H., Kwon, I.H., Choi, J.W. y Youn, J.I., “Cross-sectional study on the correlation of serum uric acid with disease severity in Korean patients with psoriasis”, Clin Exp Dermatol, 2011, 36: 473-478.

  23. Bruce, I.N., Schentag, C.T. y Gladman, D.D., “Hyperuricemia in psoriatic arthritis: prevalence and associated features”, J Clin Rheumatol, 2000, 6: 6-9.

  24. Isha, I., Jain, V.K. y Lal, H., “C-reactive protein and uric acid levels in patients with psoriasis”, Indian J Clin Biochem, 2011, 26: 309-311.

  25. Gür, M., Sahin, D.Y., Elbasan, Z., Kalkan, G.Y., Yildiz, A., Kaya, Z., Ozaltun, B. y Caylin, M., “Uric acid and high sensitive c-reactive protein are associated with subclinical thoracic aortic atherosclerosis”, J Cardiol, 2013, 61: 144-148.

  26. Ibrahim, S.E., Helmi, A., Yousef, T.M., Hassan, M.S. y Farouk, N., “Association of asymptomatic hyperuricemia and endothelial dysfunction in psoriatic arthritis”, The Egyptian Rheumatologist, 2012; 34: 83-89.

  27. Merola, J.F., Wu, S., Han, J., Choi, H.K. y Qureshi, A.A., “Psoriasis, psoriatic arthritis and risk of gout in US men and women”, Ann Rheum Dis, 2015, 74 (8): 1495-1500.

  28. Akkineni, R., Tapp, S., Tosteson, A.N., Lee, A., Miller, K.L., Choi, H.K., Zhu, Y. y Albert, D.A., “Treatment of asymptomatic hyperuricemia and prevention of vascular disease: a decision analytic approach”, J Rheumatol, 2014, 41: 739-748.

  29. Wan, J., Wang, S., Haynes, K., Denburg, M.R., Shin, D.B., Gelfand, J.M. et al., “Risk of moderate to advanced kidney disease in patients with psoriasis: population based cohort study”, bmj, 2013, 347: f5961.

  30. Daoussis, D., Panoulas, V., Toms, T., John, H., Antonopoulos, I., Nightingale, P., Douglas, K., Klocke, R. y Kitas, G.D., “Uric acid is a strong independent predictor of renal dysfunctcion in patients with rheumatoid arthritis”, Arthritis Res Ther, 2009, 11: R116.




2020     |     www.medigraphic.com